retatrutide clinical trial dose ESC 2024: improves lipid and cardiovascular risk profile in Phase II retatrutide dosing phase 2 trial

Increased cGMP leads to smooth muscle relaxation in the corpus cavernosum which can help in maintaining an erection

The SELECT trial of nearly 18,000 individuals showed that 2.4mg of semaglutide reduced heart attacks, strokes, and mortality due to CVD, with 73% fewer patients progressing to diabetes compared to the control group

Three 20-week double-blind, placebo-controlled studies each with 34-week extensions were conducted to evaluate the efficacy and safety of sitagliptin in 410 pediatric patients aged 10 to 17 years with inadequately controlled type 2 diabetes, with or without insulin therapy (HbA1c 6.5-10% for patients not on insulin, HbA1c 7-10% for patients on insulin)

It is valuable since up to 60% of people with anxiety disorders also experience depressive symptoms